SUBJECTS : Psychopharmacology | Neurology | Neuropsychology | Psychiatry | Pharmacolog
LATEST MANUSCRIPTS IN Neuropsychopharmacology Reports
- Yohei Ohtani, Fumihiko Ueno, Mitsuru Kimura, Sachio Matsushita, Masaru Mimura, Hiroyuki Uchida. Highly endorsed screening and assessment scales for alcohol problems: A systematic review. Neuropsychopharmacology reports. 2023, 43 (4): 470-481
Cited : 1Read More - Deanna Malone, Blair N Costin, Dawn MacElroy, Mashael Al-Hegelan, Julie Thompson, Yuriy Bronshteyn. Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome. Neuropsychopharmacology reports. 2023, 43 (4): 532-541Cited : 5Read More
- Mari Fukuda, Mohammad Chowdhury, Tanvir Turin Chowdhury, Hideki Tsumura, Rina Tsuchie, Minako Kinuta, Takashi Hisamatsu, Hideyuki Kanda. At-risk internet addiction and related factors among senior high school teachers in Japan based on a Nationwide survey. Neuropsychopharmacology reports. 2023, 43 (4): 553-560Cited : 0Read More
- Naotaka Izuo, Hajime Miyanishi, Daisuke Nishizawa, Takuma Fujii, Junko Hasegawa, Naomi Sato, Fumihiko Tanioka, Haruhiko Sugimura, Kazutaka Ikeda, Atsumi Nitta. DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers. Neuropsychopharmacology reports. 2023, 43 (4): 570-575Cited : 0Read More
- Munenori Katayama, So Fujishiro, Kanna Sugiura, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto. Stigmatized attitudes of medical staff toward people who use drugs and their determinants in Japanese medical facilities specialized in addiction treatment. Neuropsychopharmacology reports. 2023, 43 (4): 576-586Cited : 0Read More
- Kazuhiro Kurihara, Ayano Shiroma, Munenaga Koda, Hotaka Shinzato, Yoshikazu Takaesu, Tsuyoshi Kondo. Age-related cognitive decline is accelerated in alcohol use disorder. Neuropsychopharmacology reports. 2023, 43 (4): 587-595Cited : 1Read More
- Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J Rucker, Mikael H Sodergren. UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit/hyperactivity disorder. Neuropsychopharmacology reports. 2023, 43 (4): 596-606Cited : 2Read More
- Hu-Ming Chang, Ming-Chyi Huang, Su-Chen Fang, Shih-Ku Lin. Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment. Neuropsychopharmacology reports. 2023, 43 (4): 607-615Cited : 0Read More
- Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael W Platt, Mikael H Sodergren. An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry. Neuropsychopharmacology reports. 2023, 43 (4): 616-632Cited : 2Read More
- Kazuhiro Kurihara, Hotaka Shinzato, Yoshikazu Takaesu, Tsuyoshi Kondo. Associations between relapse and drinking behaviors in patients with alcohol use disorders: A 6-month prospective study. Neuropsychopharmacology reports. 2023, 43 (4): 633-640Cited : 1Read More
- Olena Zhabenko, Igor V Linskiy, Oleksandr I Minko, Valeriy N Kuzminov, Meike Gmeinwieser, Lars P Kiefer, Deirdre A Conroy. A qualitative assessment of insomnia in recovering alcohol-dependent patients. Neuropsychopharmacology reports. 2023, 43 (4): 641-646Cited : 0Read More
- Kensuke Miyazaki, Michiko Uchiyama. An adolescent boy with kleptomania and attention-deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report. Neuropsychopharmacology reports. 2023, 43 (4): 650-653Cited : 0Read More
- Satoshi Asakura, Naoki Yoshinaga, Hisashi Yamada, Yutaka Fujii, Nobuyuki Mitsui, Yoshihiro Kanai, Takeshi Inoue, Eiji Shimizu. Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021). Neuropsychopharmacology reports. 2023, 43 (3): 288-309Cited : 5Read More
- Yoshitaka Kawashima, Misa Yamada, Hiroki Furuie, Hiroshi Kuniishi, Kie Akagi, Tomoko Kawashima, Takamasa Noda, Mitsuhiko Yamada. Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review. Neuropsychopharmacology reports. 2023, 43 (3): 320-327Cited : 1Read More
- Yoshie Sakai, Satsuki Ito, Junya Matsumoto, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Naomi Hasegawa, Keiichiro Ishimaru, Kenichiro Miura, Ryota Hashimoto. Longitudinal characteristics of insight and clinical factors in patients with schizophrenia. Neuropsychopharmacology reports. 2023, 43 (3): 373-381Cited : 0Read More
